ProfileGDS4132 / 220250_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 39% 27% 42% 46% 35% 32% 45% 39% 55% 55% 64% 62% 52% 49% 73% 66% 66% 53% 57% 59% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101101.03339
GSM201543Muscle PCOS pioglitazone 12156.617227
GSM201544Muscle PCOS pioglitazone 161112.79542
GSM201545Muscle PCOS pioglitazone 201129.57646
GSM201829Muscle PCOS pioglitazone 23195.18935
GSM201830Muscle PCOS pioglitazon 25181.945732
GSM201831Muscle PCOS pioglitazone 271118.65745
GSM201832Muscle PCOS pioglitazone 3199.681239
GSM201833Muscle PCOS pioglitazone 41139.44655
GSM201834Muscle PCOS pioglitazone 81146.56755
GSM201835Muscle PCOS after pioglitazone 102174.73964
GSM201836Muscle PCOS after pioglitazone 122166.78662
GSM201837Muscle PCOS after pioglitazone 162123.78352
GSM201838Muscle PCOS after pioglitazone 202120.71549
GSM201839Muscle PCOS after pioglitazone 232226.8173
GSM201840Muscle PCOS after pioglitazone 252190.12166
GSM201841Muscle PCOS after pioglitazone 272179.54366
GSM201842Muscle PCOS after pioglitazone 32120.63953
GSM201843Muscle PCOS after pioglitazone 42151.70157
GSM201844Muscle PCOS after pioglitazone 82162.45559